Orthofix Medical Inc. (OFIX) Income Statement
OFIX 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsOFIX revenue and net income
Where OFIX's revenue goes
2025Each bar shows an amount and its share of revenue. OFIX kept −11.2% of revenue as net income.
OFIX profit margins
OFIX growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +2.9% | +21.3% | +15.1% | +7.6% |
| Gross profit | +1.1% | +17.8% | +12.6% | +5.9% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | +116.0% | +21.6% | +16.7% | −3.7% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
OFIX quarterly EPS vs estimates
Orthofix Medical beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 3, 2026 (estimate $-0.31).
OFIX income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M | $464.5M | $406.6M | $460.0M | $453.0M | $433.8M | $409.8M |
| Cost of revenue | $270.6M | $253.6M | $260.4M | $123.5M | $114.9M | $101.9M | $100.6M | $96.6M | $93.0M | $87.9M |
| Gross profit | $551.7M | $545.9M | $486.3M | $337.2M | $349.6M | $304.7M | $359.3M | $356.4M | $340.8M | $321.9M |
| Research & development | $57.1M | $73.6M | $80.2M | $49.1M | $49.6M | $39.1M | $34.6M | $33.2M | $29.7M | $28.8M |
| Sales, general & admin | $554.3M | $532.5M | $530.4M | $80.0M | $290.7M | $272.4M | $309.3M | $290.0M | $272.8M | $255.7M |
| Total operating expenses | $620.2M | $630.5M | $625.4M | $350.4M | $357.9M | $310.9M | $378.1M | $323.3M | $302.5M | $284.5M |
| Operating income | −$68.5M | −$84.6M | −$139.1M | −$13.3M | −$8.3M | −$6.3M | −$18.8M | $30.1M | $40.8M | $21.1M |
| Interest income | — | — | — | — | — | — | $122,000 | $828,000 | $416,000 | $763,000 |
| Interest expense | $17.5M | $29.6M | $8.6M | $1.3M | $1.8M | $2.5M | $122,000 | $828,000 | $416,000 | $0 |
| Income before taxes | −$90.8M | −$123.9M | −$148.7M | −$17.7M | −$13.5M | −$368,000 | −$27.0M | $22.9M | $36.4M | $19.0M |
| Income taxes | $1.4M | $2.1M | $2.7M | $2.0M | $24.9M | −$2.9M | $1.4M | $9.1M | $29.1M | $15.5M |
| Net income | −$92.2M | −$126.0M | −$151.4M | −$19.7M | −$38.4M | $2.5M | −$28.5M | $13.8M | $6.2M | $3.1M |
| EBITDA | $9.9M | −$18.3M | −$79.5M | $15.7M | $21.4M | $36.4M | $1.6M | $41.5M | $60.9M | $39.9M |
| EPS (diluted) | $0.54 | $0.25 | $0.02 | $0.30 | $0.86 | $0.25 | $1.47 | $1.79 | $1.63 | $1.47 |
| Gross margin | 67.1% | 68.3% | 65.1% | 73.2% | 75.3% | 74.9% | 78.1% | 78.7% | 78.6% | 78.6% |
| Operating margin | −8.3% | −10.6% | −18.6% | −2.9% | −1.8% | −1.5% | −4.1% | 6.6% | 9.4% | 5.1% |
| Net margin | −11.2% | −15.8% | −20.3% | −4.3% | −8.3% | 0.6% | −6.2% | 3.0% | 1.4% | 0.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $210.9M | $196.7M | $219.9M | $205.6M | $203.1M | $193.6M | $215.7M | $196.6M | $198.6M | $188.6M | $200.4M | $184.0M |
| Cost of revenue | $61.2M | $57.2M | $77.9M | $57.1M | $63.6M | $72.0M | $66.8M | $61.6M | $63.9M | $61.4M | $63.8M | $64.2M |
| Gross profit | $149.7M | $139.5M | $142.0M | $148.5M | $139.5M | $121.6M | $148.8M | $135.1M | $134.7M | $127.2M | $136.6M | $119.8M |
| Research & development | $15.9M | $15.3M | $15.4M | $14.8M | $15.9M | $19.8M | $18.8M | $17.3M | $18.0M | $19.5M | $18.9M | $18.6M |
| Sales, general & admin | $138.0M | $134.9M | $136.8M | $148.1M | $136.5M | $133.0M | $433.3M | $130.1M | $134.2M | $131.7M | $132.3M | $122.1M |
| Total operating expenses | $157.8M | $153.2M | $128.6M | $165.6M | $155.5M | $170.5M | $160.3M | $154.0M | $159.7M | $156.6M | $154.9M | $144.2M |
| Operating income | −$8.1M | −$13.7M | $13.5M | −$17.0M | −$16.0M | −$48.9M | −$11.5M | −$18.9M | −$24.9M | −$29.3M | −$18.3M | −$24.4M |
| Interest expense | $6.1M | $5.7M | $4.4M | $4.7M | $4.0M | $4.5M | $14.9M | $5.2M | $4.9M | $4.6M | $4.5M | $1.6M |
| Income before taxes | −$15.0M | −$20.8M | −$2.2M | −$22.3M | −$14.2M | −$52.1M | −$29.7M | −$26.6M | −$32.4M | −$35.2M | −$22.0M | −$28.4M |
| Income taxes | $801,000 | $74,000 | $30,000 | $533,000 | −$142,000 | $961,000 | −$564,000 | $751,000 | $1.1M | $851,000 | $125,000 | $472,000 |
| Net income | −$15.8M | −$20.9M | −$2.2M | −$22.8M | −$14.1M | −$53.1M | −$29.1M | −$27.4M | −$33.4M | −$36.0M | −$22.2M | −$28.9M |
| EBITDA | $4.9M | −$1.7M | $91.5M | −$3.1M | $7.7M | −$11.9M | $12.5M | −$4.6M | −$11.9M | −$14.3M | −$551,000 | −$12.5M |
| EPS (diluted) | −$0.39 | −$0.11 | $0.24 | $0.20 | $0.13 | −$0.03 | $0.02 | $0.07 | $0.05 | $0.11 | $0.03 | $0.07 |
| Gross margin | 71.0% | 70.9% | 64.6% | 72.2% | 68.7% | 62.8% | 69.0% | 68.7% | 67.8% | 67.5% | 68.2% | 65.1% |
| Operating margin | −3.9% | −7.0% | 6.1% | −8.3% | −7.9% | −25.2% | −5.3% | −9.6% | −12.5% | −15.6% | −9.1% | −13.3% |
| Net margin | −7.5% | −10.6% | −1.0% | −11.1% | −6.9% | −27.4% | −13.5% | −13.9% | −16.8% | −19.1% | −11.1% | −15.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in OFIX's financial statements (latest annual report filed February 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
OFIX financial results
In fiscal year 2025 (ended December 31, 2025), Orthofix Medical reported revenue of $822.3 million, up 2.9% from the year before. It had a net loss of $92.2 million, a net profit margin of −11.2%. Diluted earnings per share came to $0.54. Over five years revenue grew at an average rate of 15.1% a year.
See the OFIX stock overview for the latest quote and news, or the OFIX chart for price history and technical indicators.
OFIX income statement FAQ
What is Orthofix Medical's annual revenue?
Orthofix Medical reported total revenue of $822.3 million for fiscal year 2025, which ended on December 31, 2025. That was up 2.9% from $799.5 million the previous year.
Is Orthofix Medical profitable?
No. Orthofix Medical reported a net loss of $92.2 million in fiscal 2025, a net profit margin of −11.2%; its operating margin was −8.3%.
What is Orthofix Medical's gross margin?
Orthofix Medical's gross margin was 67.1% in fiscal 2025: for every $100 of revenue, Orthofix Medical kept $67 after the direct cost of its products and services.
How much does Orthofix Medical spend on research and development?
Orthofix Medical spent $57.1 million on research and development in fiscal 2025, 6.9% of revenue.
How fast is Orthofix Medical growing?
Revenue grew 15.1% a year on average over the last five fiscal years, from $406.6 million to $822.3 million.
What are Orthofix Medical's earnings per share?
Orthofix Medical earned $0.54 per diluted share in fiscal 2025, compared with $0.25 a year earlier.
When will Orthofix Medical report its next earnings?
Orthofix Medical is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens.
When does Orthofix Medical's fiscal year end?
Orthofix Medical's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 24, 2026.